Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
4
36%
Ph phase_2
1
9%
Ph phase_4
6
55%

Phase Distribution

0

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Terminated(1)

Detailed Status

Completed10
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 34 (36.4%)
Phase 46 (54.5%)

Trials by Status

completed1091%
withdrawn19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_3

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

NCT00354302
completedphase_2

Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?

NCT03208582
completedphase_3

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

NCT00043069
completedphase_3

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

NCT00054418
withdrawnphase_3

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

NCT00324714
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00354302Phase 3

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Completed
NCT03208582Phase 2

Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?

Completed
NCT00043069Phase 3

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Completed
NCT00054418Phase 3

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Completed
NCT00324714Phase 3

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Withdrawn
NCT00460733Phase 4

SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.

Completed
NCT00082277Phase 4

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

Completed
NCT00130403Phase 4

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Completed
NCT00632216Phase 4

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis

Completed
NCT00453492Phase 4

Risedronate Sodium in Post Menopausal Osteoporosis

Completed
NCT00549965Phase 4

Satisfaction and Compliance of Risedronate in PMO

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11